[Prophylaxis of malaria]

Presse Med. 1990 Dec;19(44):2026-30.
[Article in French]

Abstract

Malaria prevention involves vector control, individual protection against mosquito bites and chemoprophylaxis. Chemoprophylaxis has become more difficult in recent years owing to the spread of chloroquine-resistant P. falciparum strains. Current possibilities are chloroquine and mefloquine (with relatively poor tolerance and a few resistant strains), or the chloroquine-proguanil combination (well tolerated with some failures). Prophylaxis should not be discontinued unless transmission remains at a low level. Among inhabitants of endemic areas, prophylaxis is generally restricted to pregnant women.

Publication types

  • English Abstract

MeSH terms

  • Animals
  • Anopheles
  • Antimalarials / therapeutic use
  • Chloroquine / therapeutic use*
  • Dapsone / therapeutic use
  • Doxycycline / therapeutic use
  • Drug Combinations
  • Drug Resistance, Microbial
  • Drug Therapy, Combination
  • Humans
  • Malaria / prevention & control*
  • Mefloquine / analogs & derivatives
  • Mefloquine / therapeutic use*
  • Proguanil / therapeutic use*
  • Pyrimethamine / therapeutic use
  • Sulfadoxine / therapeutic use

Substances

  • Antimalarials
  • Drug Combinations
  • Maloprim
  • mefloquine-sulfadoxine-pyrimethamine
  • Sulfadoxine
  • Chloroquine
  • Dapsone
  • Doxycycline
  • Proguanil
  • Mefloquine
  • Pyrimethamine